CARL
Carlsmed, Inc. Common Stock
Nasdaq · usd
Carlsmed, Inc. Common Stock (CARL) trades at $14.82 (+2.00%) as of 2:22:38 PM EDT on Oct 26, 2026, -1.95% over the past month. Market cap is $396.71M, with 14.3 days to cover in short interest.
Stock performance
How Carlsmed, Inc. Common Stock (CARL) stock has performed from one day to one year, with its 52-week range.
- 1D
- +1.89%
- 1W
- +8.38%
- 1M
- -1.95%
- YTD
- +19.88%
- 1Y
- +9.34%
- 52-wk range
- $8.50 – $17.23
Key statistics
Today's trading snapshot for CARL: day range, open, previous close, volume and market cap.
- Day range
- $14.51 – $15.49
- Open
- $14.63
- Prev close
- $14.53
- Volume
- 69.5K
- Market cap
- $396.71M
- Shares out
- 27.3M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Carlsmed, Inc. Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 6.27
- P/B
- 4.71
- P/FCF
- —
- ROE
- -43.1%
- ROA
- -30.8%
- Debt/Equity
- 0.18
- Div yield
- 0.00%
As of Oct 23, 2026
8-K filings
Material corporate events Carlsmed, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Equity compensation grantSep 30, 2026
On the Transition Date, Mr. Heppenstall was granted (i) an award of stock options to purchase shares of the Company's common stock ... pursuant to an inducement stock option agreement and (ii) an award of Company restricted stock units ... pursuant to an inducement restricted stock unit agreement.
- Equity compensation grantSep 8, 2026
On September 8, 2026, Mr. Bertolini was also granted 50,000 stock options to purchase shares of the Company's common stock.
- Annual meeting resultsJun 3, 2026
Carlsmed, Inc. held its 2026 Annual Meeting of Stockholders on June 3, 2026. At the Annual Meeting, the Company's stockholders voted on two proposals... The Company's stockholders elected the following two Class I directors to serve on the Company's board of directors until the 2029 annual meeting of stockholders.
- Preliminary resultsJan 12, 2026
On January 12, 2026, the Company issued a press release announcing its preliminary and unaudited revenue for the year ended December 31, 2025.
- Credit facilityOct 30, 2025
On October 29, 2025, Carlsmed, Inc. entered into the Fifth Amendment to the Loan and Security Agreement with Customers Bank. The Fifth Amendment provides the Company with a credit facility consisting of (i) a term loan in the principal amount of up to $50.0 million, $17.5 million of which is contingent upon the achievement of requisite revenue milestones, and (ii) a $10.0 million non-formula revolving line of credit that is immediately available in full, provided that at no time shall the aggregate amount advanced under the Term Loan and the Non-Formula Revolving Line exceed $50.0 million.
Dividend history and stock splits
Carlsmed, Inc. Common Stock's recent dividend payments and stock splits.
Dividends
No recent dividends.
Splits
- 1-for-200Jun 29, 2004
CARL short interest
How heavily CARL is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 14.3
- Short interest
- 1.05M
- Avg volume
- 73.79K
As of · reported to FINRA twice monthly.
CARL news
The latest news and headlines about Carlsmed, Inc. Common Stock (CARL).
- Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior SystempositiveGlobeNewswire Inc.· Oct 14, 2026
- Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen MedicalpositiveGlobeNewswire Inc.· Sep 15, 2026
- Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual MeetingpositiveGlobeNewswire Inc.· Dec 3, 2025
- Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and SecretarypositiveGlobeNewswire Inc.· Sep 29, 2025
- Carlsmed, Inc. Selected for Inclusion in Russell 2000® IndexpositiveGlobeNewswire Inc.· Sep 22, 2025
Frequently asked questions
What is the Carlsmed, Inc. Common Stock (CARL) stock price today?
Carlsmed, Inc. Common Stock (CARL) is trading at $14.82 (+2.00% on the day) as of 2:22:38 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Carlsmed, Inc. Common Stock?
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology…
What is the short interest in CARL?
As of Sep 30, 2026, CARL has 1.05M shares short and 14.3 days to cover.
What exchange is CARL listed on?
Carlsmed, Inc. Common Stock (CARL) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.
Build with AI
Build an analysis of CARL with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a CARL analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.